| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
 |
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
| ACTG
372 |
| Long-term
study of virologic success or failure in adults
receiving indinavir
plus nucleoside
analogs |
| August
1997 |
| January
2002 |
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
| CT
CS-GT005 |
| Long-term
evaluation of safety in gene-therapy
studies |
| June
1998 |
| Ongoing
follow-up, no close date |
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
| DMP
266 |
| Evaluate
the efficacy of DMP-266
alone or in combination with indinavir |
| March
1996 |
| May
2002 |
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
| MK
004 |
| HIV
vaccine study for adults with undetectable viral
load |
| March
2000 |
| July
2003 |
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
| RO
T-20-301 |
| Compare
T-20/Ro 29-9800 + an optimum regimen or the optimum
regimen alone |
| February
2001 |
| June
2003 |
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|
| |
|
|
| Study
ID: |
Description:
|
| Open
Date: |
| Estimated
close date: |
|
|
|